Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotoxins (author's transl)]

G Richer, F K Jansen, P Gros

    La Nouvelle Presse Medicale
    |April 10, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Immunotoxins, combining antibodies with toxins, selectively target and kill cancer cells expressing specific antigens. Promising in vitro and in vivo studies suggest potential cancer treatment applications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Temperate Forest Floor Bryophytes Functionally Respond to Small-Scale Variability in Water, Light and Nutrient Availability.

    Ecology and evolution·2025
    Same author

    Search for Light Dark Matter with NEWS-G at the Laboratoire Souterrain de Modane Using a Methane Target.

    Physical review letters·2025
    Same author

    Case report of a primary ectopic extradural and extraspinal meningioma of the brachial plexus.

    Neuro-Chirurgie·2024
    Same author

    Inflammatory markers and BDNF in obstructive sleep apnea (OSA) in Parkinson's disease (PD).

    Sleep medicine·2022
    Same author

    Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.

    Cell death and differentiation·2016
    Same author

    Charmonium and <i>e</i><sup>+</sup><i>e</i><sup>-</sup> pair photoproduction at mid-rapidity in ultra-peripheral Pb-Pb collisions at [Formula: see text].

    The European physical journal. C, Particles and fields·2015
    Same journal

    [Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

    La Nouvelle presse medicale·2016
    Same journal

    [Cutaneous systemic angiitis in hairy cell leukemia].

    La Nouvelle presse medicale·1982
    Same journal

    [Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

    La Nouvelle presse medicale·1982
    Same journal

    [Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

    La Nouvelle presse medicale·1982
    Same journal

    [Relation between psychological stress and obstetrical complications. Preliminary data].

    La Nouvelle presse medicale·1982
    Same journal

    [Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

    La Nouvelle presse medicale·1982
    See all related articles

    Area of Science:

    • Biochemistry
    • Immunology
    • Oncology

    Context:

    • Immunotoxins are engineered molecules comprising an antibody linked to a toxic peptide.
    • The antibody component targets specific cellular antigens, ensuring localized delivery of the toxin.
    • Monoclonal antibodies, derived from cell fusion techniques, offer high specificity for malignant cell antigens.

    Purpose:

    • To explore the targeted cytotoxic potential of immunotoxins against malignant cells.
    • To evaluate the efficacy of immunotoxins in both in vitro and in vivo experimental models.
    • To assess the feasibility of immunotoxins as a therapeutic strategy for cancer treatment.

    Summary:

    • Immunotoxins leverage antibody-antigen recognition for targeted delivery of cytotoxic payloads.

    Related Experiment Videos

  • Experiments demonstrate specific activity against malignant cells in vitro.
  • In vivo studies in mice corroborate the in vitro findings, showing efficacy.
  • The targeted nature of immunotoxins minimizes damage to healthy cells.

    • Impact:

    • Immunotoxins show significant promise for targeted cancer therapy.
    • Potential applications extend beyond oncology to other pharmacological uses.
    • Further research may lead to novel treatments for various diseases.
    • This approach offers a more precise alternative to conventional therapies.